Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Evaluation of Apoptosis Induced by Celecoxib Loaded Liposomes in Isolated Rat Hepatocytes

Mojtaba Kalantar 1 , Mohsen Rezaei 1 , 2 , * , Eskandar Moghimipour 3 , Neda Bavarsad 4 , Heibatallah Kalantari 1 , Golnaz Varnaseri 1 and Arash Forouzan 5
Authors Information
1 Department of Pharmacology and Toxicology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Toxicology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
3 Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Nanotechnology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Department of Emergency, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: August 01, 2015, 10 (3); e25421
  • Published Online: August 30, 2015
  • Article Type: Research Article
  • Received: January 18, 2015
  • Revised: June 10, 2015
  • Accepted: July 12, 2015
  • DOI: 10.17795/jjnpp-25421

To Cite: Kalantar M, Rezaei M, Moghimipour E, Bavarsad N, Kalantari H, et al. Evaluation of Apoptosis Induced by Celecoxib Loaded Liposomes in Isolated Rat Hepatocytes, Jundishapur J Nat Pharm Prod. 2015 ; 10(3):e25421. doi: 10.17795/jjnpp-25421.

Abstract
Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ferreira AJ, Cemlyn-Jones J, Robalo Cordeiro C. Nanoparticles, nanotechnology and pulmonary nanotoxicology. Rev Port Pneumol. 2013; 19(1): 28-37[DOI][PubMed]
  • 2. Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett. 2006; 160(2): 121-6[DOI][PubMed]
  • 3. Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev. 2009; 61(6): 457-66[DOI][PubMed]
  • 4. Linkov I, Satterstrom FK, Corey LM. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine. 2008; 4(2): 167-71[DOI][PubMed]
  • 5. Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci U S A. 2003; 100(10): 6039-44[DOI][PubMed]
  • 6. El-Ansary A, Al-Daihan S. On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol. 2009; 2009: 754810[DOI][PubMed]
  • 7. Chan VS. Nanomedicine: An unresolved regulatory issue. Regul Toxicol Pharmacol. 2006; 46(3): 218-24[DOI][PubMed]
  • 8. Borm PJ, Muller-Schulte D. Nanoparticles in drug delivery and environmental exposure: same size, same risks? Nanomedicine (Lond). 2006; 1(2): 235-49[DOI][PubMed]
  • 9. Yamakawa N, Suemasu S, Okamoto Y, Tanaka K, Ishihara T, Asano T, et al. Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity. J Med Chem. 2012; 55(11): 5143-50[DOI][PubMed]
  • 10. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis. Mol Carcinog. 1999; 25(4): 231-40[DOI]
  • 11. Strillacci A, Griffoni C, Lazzarini G, Valerii MC, Di Molfetta S, Rizzello F, et al. Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells. Br J Cancer. 2010; 103(7): 975-86[DOI][PubMed]
  • 12. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002; 94(4): 252-66[PubMed]
  • 13. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000; 342(26): 1946-52[DOI][PubMed]
  • 14. Gaosong W, Jilin Y, Fang D, Shengquan Z, Xingrui L. Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells. J Huazhong Univ Sci Technolog Med Sci. 2005; 25(1): 42-4[DOI]
  • 15. Jendrossek V. Targeting apoptosis pathways by Celecoxib in cancer. Cancer Lett. 2013; 332(2): 313-24[DOI][PubMed]
  • 16. Vaish V, Sanyal SN. Role of Sulindac and Celecoxib in chemoprevention of colorectal cancer via intrinsic pathway of apoptosis: exploring NHE-1, intracellular calcium homeostasis and Calpain 9. Biomed Pharmacother. 2012; 66(2): 116-30[DOI][PubMed]
  • 17. Piplani H, Vaish V, Sanyal SN. Dolastatin 15, a mollusk linear peptide, and Celecoxib, a selective cyclooxygenase-2 inhibitor, prevent preneoplastic colonic lesions and induce apoptosis through inhibition of the regulatory transcription factor NF-kappaB and an inflammatory protein, iNOS. Eur J Cancer Prev. 2012; 21(6): 511-22[DOI][PubMed]
  • 18. Hsu AL. The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2. J Biol Chem. 2000; 275(15): 11397-403[DOI]
  • 19. He TC, Chan TA, Vogelstein B, Kinzler KW. PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs. Cell. 1999; 99(3): 335-45[DOI]
  • 20. Herrmann C, Block C, Geisen C, Haas K, Weber C, Winde G, et al. Sulindac sulfide inhibits Ras signaling. Oncogene. 1998; 17(14): 1769-76[DOI]
  • 21. Liu DB, Hu GY, Long GX, Qiu H, Mei Q, Hu GQ. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Acta Pharmacol Sin. 2012; 33(5): 682-90[DOI][PubMed]
  • 22. Hussain S, Al-Nsour F, Rice AB, Marshburn J, Yingling B, Ji Z, et al. Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes. ACS Nano. 2012; 6(7): 5820-9[DOI][PubMed]
  • 23. Kang KW, Chun MK, Kim O, Subedi RK, Ahn SG, Yoon JH, et al. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomedicine. 2010; 6(2): 210-3[DOI][PubMed]
  • 24. Moghimipour E, Handali S. Utilization of thin film method for preparation of celecoxib loaded liposomes. Adv Pharm Bull. 2012; 2(1): 93-8[DOI][PubMed]
  • 25. Azqueta A, Collins AR. The essential comet assay: a comprehensive guide to measuring DNA damage and repair. Arch Toxicol. 2013; 87(6): 949-68[DOI][PubMed]
  • 26. Lorenzo Y, Costa S, Collins AR, Azqueta A. The comet assay, DNA damage, DNA repair and cytotoxicity: hedgehogs are not always dead. Mutagenesis. 2013; 28(4): 427-32[DOI][PubMed]
  • 27. Heibatullah K, Marzieh P, Arefeh I, Ebrahim M. Genotoxicity determinations of coriander drop and extract of Coriander Sativum cultured fibroblast of rat embryo by comet assay. Saudi Pharmaceutical Journal. 2008;
  • 28. Wong V, Szeto Y, Collins AR, Benzie I. The comet assay: a biomonitoring tool for nutraceutical research. Curr Top Nutraceutical Res. 2005; 3(1): 1-14
  • 29. Wood AJ, FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001; 345(6): 433-42[DOI][PubMed]
  • 30. Kim SH, Song SH, Kim SG, Chun KS, Lim SY, Na HK, et al. Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target. J Cancer Res Clin Oncol. 2004; 130(9): 551-60[DOI][PubMed]
  • 31. Piplani H, Rana C, Vaish V, Vaiphei K, Sanyal SN. Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation. Biochim Biophys Acta. 2013; 1830(11): 5142-56[DOI][PubMed]
  • 32. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, et al. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 2000; 60(24): 6846-50[PubMed]
  • 33. Butler M. Animal cell culture and technology. 2003;
  • 34. Zhou R, Zhang LZ, Wang RZ. Effect of celecoxib on proliferation, apoptosis, and survivin expression in human glioma cell line U251. Chin J Cancer. 2010; 29(3): 294-9[PubMed]
  • 35. Li WZ, Wang XY, Ding YQ. [Celecoxib induces cell cycle arrest and apoptosis in human tongue squamous carcinoma cell line Tca8113]. Nan Fang Yi Ke Da Xue Xue Bao. 2010; 30(3): 486-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments